Peter Edman new Chief Scientific Officer at Biovitrum AB
Peter Edman, PhD, Associate Professor, 54, will join Biovitrum as Chief Scientific Officer. He is leaving his current position as Vice President and Global Project Director, Global Development, at AstraZeneca.
Peter Edman has previously held a number of senior research leadership positions within Pharmacia, Astra and AstraZeneca. He has also held a position as Director and Associate Professor at the Swedish Medical Product Agency. In addition, Peter Edman has comprehensive scientific qualifications from the University of Uppsala, which has rendered him a Ph.D. and an Associate Professor title in biochemistry. Moreover, Peter has been Professor in Pharmaceutical Formulation and Adjunct Professor in Drug Delivery at the Faculty of Pharmacy, Uppsala University.
Peter Edman will assume his position during the second quarter 2008.
Other news from the department people

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.